Another new drug for type 2 diabetes, called Prandin (repaglinide)

    You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).

    It's the first of a new class...the meglitinides.

    Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote